The activation of the NF-κB pathway dependent on IQGAP2 is probably the main reason for immunosuppression in DLBCL because of its induction of immune checkpoint molecules such as PD-L1 [41]. Here, NFKB1 is linked to diffuse large B-cell lymphoma.